DGCR5 has been associated with the prognosis of both lung cancer and HCC [14, 17], and in our study, we found that a lower DGCR5 level correlated with a poor prognosis in patients with PDAC. The gene discussed is DGCR5; the disease is hepatocellular carcinoma.